Global Compounding Pharmacy Market Research Report 2023

Report Format: PDF   |   Report ID: 5669287   |   Published Date: February 2023   |   Pages:  300  

Global Compounding Pharmacy Market Size was estimated at USD 11582.73 million in 2022 and is projected to reach USD 13983.9 million by 2028, exhibiting a CAGR of 2.73% during the forecast period.
Global Compounding Pharmacy Market Overview:
Global Compounding Pharmacy Market Report 2022 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Compounding Pharmacy involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Compounding Pharmacy Market
The Compounding Pharmacy Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Compounding Pharmacy Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Compounding Pharmacy Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Compounding Pharmacy Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Compounding Pharmacy market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Compounding Pharmacy Market Segmentation
Global Compounding Pharmacy Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Compounding Pharmacy market has been segmented into:
PIA
PAA
CUPM
PDA
SAPM
By Application, Compounding Pharmacy market has been segmented into:
Consumers Aged 18 and Younger
Consumers Aged 19 to 44
Consumers Aged 45 to 64
Consumers Aged 65 and Older
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Compounding Pharmacy market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Compounding Pharmacy market.
Top Key Players Covered in Compounding Pharmacy market are:
PharMEDium Services
B. Braun Group
Fagron
Wedgewood Pharmacy
New Compounding Pharma
Medisca
Fresenius Kabi
Advanced Pharma
AIN GROUP
Nihon Chouzai
Sogo Medical
Dougherty's Pharmacy
Apollo Pharmacy
Downing Labs
Qol Holdings
Olympia Pharmacy
PUMCH
Triangle Compounding Pharmacy
Peking University First Hospital
Affiliated Hospital of Guangdong Public Institution of Medicine
Lorraine's Pharmacy
PLAGH
Institutional Pharmacy Solutions
Ruijin Hospital
Belle Sante
Byculla PharmacyandStores
Royal Chemists
Village Compounding Pharmacy
Specialist Pharmacy
Objective to buy this Report:
1. Compounding Pharmacy analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Compounding Pharmacy market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Compounding Pharmacy Market by Type
 5.1 Compounding Pharmacy Market Overview Snapshot and Growth Engine
 5.2 Compounding Pharmacy Market Overview
 5.3 PIA
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 PIA: Geographic Segmentation
 5.4 PAA
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 PAA: Geographic Segmentation
 5.5 CUPM
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 CUPM: Geographic Segmentation
 5.6 PDA
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 PDA: Geographic Segmentation
 5.7 SAPM
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size (2016-2028F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 SAPM: Geographic Segmentation

Chapter 6: Compounding Pharmacy Market by Application
 6.1 Compounding Pharmacy Market Overview Snapshot and Growth Engine
 6.2 Compounding Pharmacy Market Overview
 6.3 Consumers Aged 18 and Younger
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Consumers Aged 18 and Younger: Geographic Segmentation
 6.4 Consumers Aged 19 to 44
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Consumers Aged 19 to 44: Geographic Segmentation
 6.5 Consumers Aged 45 to 64
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Consumers Aged 45 to 64: Geographic Segmentation
 6.6 Consumers Aged 65 and Older
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size (2016-2028F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Consumers Aged 65 and Older: Geographic Segmentation

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Positioning
  7.1.2 Compounding Pharmacy Sales and Market Share By Players
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Compounding Pharmacy Industry Concentration Ratio (CR5 and HHI)
  7.1.6 Top 5 Compounding Pharmacy Players Market Share
  7.1.7 Mergers and Acquisitions
  7.1.8 Business Strategies By Top Players
 7.2 PHARMEDIUM SERVICES
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Operating Business Segments
  7.2.5 Product Portfolio
  7.2.6 Business Performance
  7.2.7 Key Strategic Moves and Recent Developments
  7.2.8 SWOT Analysis
 7.3 B. BRAUN GROUP
 7.4 FAGRON
 7.5 WEDGEWOOD PHARMACY
 7.6 NEW COMPOUNDING PHARMA
 7.7 MEDISCA
 7.8 FRESENIUS KABI
 7.9 ADVANCED PHARMA
 7.10 AIN GROUP
 7.11 NIHON CHOUZAI
 7.12 SOGO MEDICAL
 7.13 DOUGHERTY'S PHARMACY
 7.14 APOLLO PHARMACY
 7.15 DOWNING LABS
 7.16 QOL HOLDINGS
 7.17 OLYMPIA PHARMACY
 7.18 PUMCH
 7.19 TRIANGLE COMPOUNDING PHARMACY
 7.20 PEKING UNIVERSITY FIRST HOSPITAL
 7.21 AFFILIATED HOSPITAL OF GUANGDONG PUBLIC INSTITUTION OF MEDICINE
 7.22 LORRAINE'S PHARMACY
 7.23 PLAGH
 7.24 INSTITUTIONAL PHARMACY SOLUTIONS
 7.25 RUIJIN HOSPITAL
 7.26 BELLE SANTE
 7.27 BYCULLA PHARMACYANDSTORES
 7.28 ROYAL CHEMISTS
 7.29 VILLAGE COMPOUNDING PHARMACY
 7.30 SPECIALIST PHARMACY

Chapter 8: Global Compounding Pharmacy Market Analysis, Insights and Forecast, 2016-2028
 8.1 Market Overview
 8.2 Historic and Forecasted Market Size By Type
  8.2.1 PIA
  8.2.2 PAA
  8.2.3 CUPM
  8.2.4 PDA
  8.2.5 SAPM
 8.3 Historic and Forecasted Market Size By Application
  8.3.1 Consumers Aged 18 and Younger
  8.3.2 Consumers Aged 19 to 44
  8.3.3 Consumers Aged 45 to 64
  8.3.4 Consumers Aged 65 and Older

Chapter 9: North America Compounding Pharmacy Market Analysis, Insights and Forecast, 2016-2028
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Type
  9.4.1 PIA
  9.4.2 PAA
  9.4.3 CUPM
  9.4.4 PDA
  9.4.5 SAPM
 9.5 Historic and Forecasted Market Size By Application
  9.5.1 Consumers Aged 18 and Younger
  9.5.2 Consumers Aged 19 to 44
  9.5.3 Consumers Aged 45 to 64
  9.5.4 Consumers Aged 65 and Older
 9.6 Historic and Forecast Market Size by Country
  9.6.1 U.S.
  9.6.2 Canada
  9.6.3 Mexico

Chapter 10: Europe Compounding Pharmacy Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 PIA
  10.4.2 PAA
  10.4.3 CUPM
  10.4.4 PDA
  10.4.5 SAPM
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Consumers Aged 18 and Younger
  10.5.2 Consumers Aged 19 to 44
  10.5.3 Consumers Aged 45 to 64
  10.5.4 Consumers Aged 65 and Older
 10.6 Historic and Forecast Market Size by Country
  10.6.1 Germany
  10.6.2 U.K.
  10.6.3 France
  10.6.4 Italy
  10.6.5 Russia
  10.6.6 Spain
  10.6.7 Rest of Europe

Chapter 11: Asia-Pacific Compounding Pharmacy Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 PIA
  11.4.2 PAA
  11.4.3 CUPM
  11.4.4 PDA
  11.4.5 SAPM
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Consumers Aged 18 and Younger
  11.5.2 Consumers Aged 19 to 44
  11.5.3 Consumers Aged 45 to 64
  11.5.4 Consumers Aged 65 and Older
 11.6 Historic and Forecast Market Size by Country
  11.6.1 China
  11.6.2 India
  11.6.3 Japan
  11.6.4 Singapore
  11.6.5 Australia
  11.6.6 New Zealand
  11.6.7 Rest of APAC

Chapter 12: Middle East & Africa Compounding Pharmacy Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 PIA
  12.4.2 PAA
  12.4.3 CUPM
  12.4.4 PDA
  12.4.5 SAPM
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Consumers Aged 18 and Younger
  12.5.2 Consumers Aged 19 to 44
  12.5.3 Consumers Aged 45 to 64
  12.5.4 Consumers Aged 65 and Older
 12.6 Historic and Forecast Market Size by Country
  12.6.1 Turkey
  12.6.2 Saudi Arabia
  12.6.3 Iran
  12.6.4 UAE
  12.6.5 Africa
  12.6.6 Rest of MEA

Chapter 13: South America Compounding Pharmacy Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 PIA
  13.4.2 PAA
  13.4.3 CUPM
  13.4.4 PDA
  13.4.5 SAPM
 13.5 Historic and Forecasted Market Size By Application
  13.5.1 Consumers Aged 18 and Younger
  13.5.2 Consumers Aged 19 to 44
  13.5.3 Consumers Aged 45 to 64
  13.5.4 Consumers Aged 65 and Older
 13.6 Historic and Forecast Market Size by Country
  13.6.1 Brazil
  13.6.2 Argentina
  13.6.3 Rest of SA

Chapter 14 Investment Analysis

Chapter 15 Analyst Viewpoint and Conclusion


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Publisher: Introspective Market Research
Choose License
Limited Time Offer
Related Reports

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support

Frequently Asked Questions (FAQ)

Global Compounding Pharmacy Market Size was estimated at USD 11582.73 million in 2022 and is projected to reach USD 13983.9 million by 2028.

PharMEDium Services, B. Braun Group, Fagron, Wedgewood Pharmacy, New Compounding Pharma, Medisca, Fresenius Kabi, Advanced Pharma, AIN GROUP, Nihon Chouzai, Sogo Medical, Dougherty’s Pharmacy, Apollo Pharmacy, Downing Labs, Qol Holdings, Olympia Pharmacy, PUMCH, Triangle Compounding Pharmacy, Peking University First Hospital, Affiliated Hospital of Guangdong Public Institution of Medicine, Lorraines Pharmacy, PLAGH, Institutional Pharmacy Solutions, Ruijin Hospital, Belle Sante, Byculla PharmacyandStores, Royal Chemists, Village Compounding Pharmacy, Specialist Pharmacy

North America,Europe,Asia-Pacific,South America,Middle East & Africa